Companies
NIBSC
the National Institute for Biological Standards and Control is the WHO Collaborating Centre for Biological Standardization, holding roughly 90 percent of the WHO International Standards that calibrate the potency of vaccines, hormones and biologics globally.
- Country
- United Kingdom
WHO Collaborating Centre, ~90% of WHO International Standards
eu
Coverage
| CN | EU | IN | US | |
|---|---|---|---|---|
| monitoring-conservation | ✓ | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Funding | NIBSC receives revenue from fees charged for services (including sale of standards) and research funding from DHSC. | assets.publishing.service.gov.uk |
| Capacity | Produces all lyophilised products in the NIBSC catalogue using industrial freeze dryers; also performs contract work for external parties. | contractsfinder.service.gov.uk |
| Certification | ISO 17025 compliance for some testing under a UKAS assessed Quality Management System. | nibsc.org |
| Regulatory approval | UK’s official National Control Laboratory and stand-alone National Control Laboratory as of January 1, 2021. | nibsc.org |
| Production site | South Mimms, Hertfordshire, UK. | piglix.com · bipm.org |
| Headcount | Around 300 staff (approx. 200 scientists) in some reports; around 1,220 total full-time equivalents for the MHRA agency in 2013/14. | piglix.com · assets.publishing.service.gov.uk · bipm.org |
| Revenue | NIBSC operational income was £13.8m for the year to December 2013. medium confidence | assets.publishing.service.gov.uk |
Independent sources: assets.publishing.service.gov.uk · bipm.org · contractsfinder.service.gov.uk · piglix.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Reference materials & certified reference strains | monitoring-conservation | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.